BioSenic provides update regarding current license agreement with Phebra
INSIDE INFORMATION Maintenance of the license isnow subject to the launch of the OATO Phase III before May 2024instead of 31 May 2023 Parties also…
Stay updated with breaking news from Ib Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
INSIDE INFORMATION Maintenance of the license isnow subject to the launch of the OATO Phase III before May 2024instead of 31 May 2023 Parties also…
INSIDE INFORMATION Maintenance of the license is now subject to the launch of the OATO Phase III before May 2024 instead of 31 May 2023 Parties also currently negotiating a potential renegotiation... | May 29, 2023
INSIDE INFORMATION Potential license agreement to produce and commercialize original and transformed ALLOB cells BioSenic to potentially receive royalty...
GERMANTOWN, Md., May 22, 2023 -- Orgenesis Inc. , a global biotech company working to unlock the full potential of cell and gene therapies , today announced the first graduating class from a... | May 22, 2023
REGULATED INFORMATION ALLOB Phase IIb topline results foreseen in July/August 2023Ongoing discussions for key partnerships with lead clinical assets Mont-Saint-Guibert, Belgium, May 22nd,... | May 22, 2023